<--- Back to Details
First PageDocument Content
Microbiology / HIV/AIDS / Virology / Integrase / HIV / Nef / Management of HIV/AIDS / Zidovudine / Retrovirus / Discovery and development of integrase inhibitors / Discovery and development of HIV-protease inhibitors
Date: 2013-11-27 16:23:21
Microbiology
HIV/AIDS
Virology
Integrase
HIV
Nef
Management of HIV/AIDS
Zidovudine
Retrovirus
Discovery and development of integrase inhibitors
Discovery and development of HIV-protease inhibitors

June 17, 2009  Chemicals Targeting an HIV‐1 Nef/Host Cell Kinase Complex as Novel Anti‐ Retroviral Compounds    Damilola A. Adepegba, Department of Natural Sciences, University of Maryland 

Add to Reading List

Source URL: www.csb.pitt.edu

Download Document from Source Website

File Size: 68,05 KB

Share Document on Facebook

Similar Documents

June 17, 2009   Chemicals Targeting an HIV‐1 Nef/Host Cell Kinase Complex as Novel Anti‐ Retroviral Compounds    Damilola A. Adepegba, Department of Natural Sciences, University of Maryland 

June 17, 2009  Chemicals Targeting an HIV‐1 Nef/Host Cell Kinase Complex as Novel Anti‐ Retroviral Compounds    Damilola A. Adepegba, Department of Natural Sciences, University of Maryland 

DocID: 1qLnJ - View Document

HIV-1 RT p51 subunit Human Immunodeficiency Virus1 Reverse Transcriptase recombinant, E. coli Cat. No.

HIV-1 RT p51 subunit Human Immunodeficiency Virus1 Reverse Transcriptase recombinant, E. coli Cat. No.

DocID: O3BG - View Document

HIV-1 RT heterodimer Human Immunodeficiency Virus1 Reverse Transcriptase recombinant, E. coli Cat. No.

HIV-1 RT heterodimer Human Immunodeficiency Virus1 Reverse Transcriptase recombinant, E. coli Cat. No.

DocID: NV7P - View Document

AIDS InfoNet  www.aidsinfonet.org Fact Sheet Number 106

AIDS InfoNet www.aidsinfonet.org Fact Sheet Number 106

DocID: kfp3 - View Document

Predicting/Providing Substantial Evidence of Clinical Benefit for New Drug Approvals Albert Deisseroth, Division of Hematology Products February 27, 2013

Predicting/Providing Substantial Evidence of Clinical Benefit for New Drug Approvals Albert Deisseroth, Division of Hematology Products February 27, 2013

DocID: ikIg - View Document